Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16
about
A Little Help From the Follicles: Understanding the Germinal Center Response to Human Immunodeficiency Virus 1 Infection and Prophylactic Vaccines.Diffusion of Immunoglobulin G in Shed Vaginal Epithelial Cells and in Cell-Free Regions of Human Cervicovaginal Mucus.Systemic and topical use of monoclonal antibodies to prevent the sexual transmission of HIV.Antibody-mediated immune exclusion of HIV.Antibody Functional Assays as Measures of Fc Receptor-Mediated Immunity to HIV - New Technologies and their Impact on the HIV Vaccine Field.The particle in the spider's web: transport through biological hydrogels.A Functional Role for Antibodies in Tuberculosis.Tumor antigen CA125 suppresses antibody-dependent cellular cytotoxicity (ADCC) via direct antibody binding and suppressed Fc-γ receptor engagementMucus and Mucins: do they have a role in the inhibition of the human immunodeficiency virus?Systems serology: profiling vaccine induced humoral immunity against HIV.Non-Neutralizing Antibodies Directed against HIV and Their Functions.Protective Effect of Vaccine Promoted Neutralizing Antibodies against the Intracellular Pathogen Chlamydia trachomatis.Beyond binding: antibody effector functions in infectious diseases.CA125 suppresses amatuximab immune-effector function and elevated serum levels are associated with reduced clinical response in first line mesothelioma patients.Progress in HIV vaccine developmentTertiary Lymphoid Structures: Autoimmunity Goes Local
P2860
Q30234577-8F27BB95-A077-4688-9EB8-7B7D0F615A50Q36064735-81E74C3F-4CBD-485E-8296-419A65B2B59BQ38688524-779E88D7-3473-458F-98D6-B5E98CB82525Q38830501-2317770F-E19C-4CDE-A0C2-45C23255BF04Q39189458-18429DCC-68C9-400E-9FC9-719C9F1E329FQ39350747-EB3C8D77-75B0-49C1-BE32-2E87AEB02D5FQ39352413-F1A8C681-EE92-49AC-B6FE-A6709C4780E6Q41592587-55A94803-3732-487A-902B-D4D72BF894C1Q41922735-EB9E42C7-F2B6-4A48-8AC6-6E85B2978F1BQ47104983-25AA7322-C96A-4D00-9F60-9A63D2DB584DQ47139556-45F04416-5358-4466-95B1-6359520EA45EQ47194154-8BBB821D-4D6F-44EC-AC7D-266D7BD27289Q47602559-5A69CA6A-C2AF-4ACD-B496-9C78DA2B5087Q52590080-B0EF79C9-00D5-4993-BA13-2EF54D71D273Q56970600-26413435-ABDD-45E9-8BB6-45D2E0B5C403Q58746430-4AF33B7C-D985-4479-B2C7-DCBCE92922F6
P2860
Enhanced binding of antibodies generated during chronic HIV infection to mucus component MUC16
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 09 March 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhanced binding of antibodies ...... ction to mucus component MUC16
@en
Enhanced binding of antibodies ...... tion to mucus component MUC16.
@nl
type
label
Enhanced binding of antibodies ...... ction to mucus component MUC16
@en
Enhanced binding of antibodies ...... tion to mucus component MUC16.
@nl
prefLabel
Enhanced binding of antibodies ...... ction to mucus component MUC16
@en
Enhanced binding of antibodies ...... tion to mucus component MUC16.
@nl
P2093
P2860
P50
P356
P1433
P1476
Enhanced binding of antibodies ...... ction to mucus component MUC16
@en
P2093
Alison Mahan
Anais Chapel
Anna Licht
Arangassery Rosemary Bastian
Archer Smith
Arthur Kim
Bronwyn Gunn
David Malaspina
Galit Alter
Georg Lauer
P2860
P2888
P304
P356
10.1038/MI.2016.8
P577
2016-03-09T00:00:00Z